Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

Peter C. Austin · Multivariate Behavioral Research · 2011 · 11.9K citations · Full text

Public Health, Biostatistics, Causal Inference +15

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

Jonathan A C Sterne, Ian R. White, John B. Carlin et al. · BMJ · 2009 · 7.2K citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text

Medicine, Oncology, Pharmacology +11

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg et al. · The Lancet · 2016 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +11

A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data

Carl van Walraven, Peter C. Austin, Alison Jennings et al. · Medical Care · 2009 · 2.2K citations

Public Health, Biostatistics, Internal Medicine +17